211 related articles for article (PubMed ID: 12001033)
21. Identifying and managing morphologic complications of HIV and HAART.
Currier J; Carpenter C; Daar E; Kotler D; Wanke C
AIDS Read; 2002 Mar; 12(3):114-9, 124-5. PubMed ID: 11966241
[TBL] [Abstract][Full Text] [Related]
22. HIV infection and advanced age emerging epidemiological, clinical, and management issues.
Manfredi R
Ageing Res Rev; 2004 Jan; 3(1):31-54. PubMed ID: 15164725
[TBL] [Abstract][Full Text] [Related]
23. Metabolic complications associated with the use of highly active antiretroviral therapy in HIV-1-infected adults.
Monier PL; Wilcox R
Am J Med Sci; 2004 Jul; 328(1):48-56. PubMed ID: 15254441
[TBL] [Abstract][Full Text] [Related]
24. A high incidence of lactic acidosis and symptomatic hyperlactatemia in women receiving highly active antiretroviral therapy in Soweto, South Africa.
Bolhaar MG; Karstaedt AS
Clin Infect Dis; 2007 Jul; 45(2):254-60. PubMed ID: 17578788
[TBL] [Abstract][Full Text] [Related]
25. Weight and body shape changes in a treatment-naive population after 6 months of nevirapine-based generic highly active antiretroviral therapy in South India.
Saghayam S; Kumarasamy N; Cecelia AJ; Solomon S; Mayer K; Wanke C
Clin Infect Dis; 2007 Jan; 44(2):295-300. PubMed ID: 17173234
[TBL] [Abstract][Full Text] [Related]
26. Lactic acidosis in an HIV-infected patient receiving highly active antiretroviral therapy.
Patel V; Hedayati SS
Nat Clin Pract Nephrol; 2006 Feb; 2(2):109-14; quiz 115. PubMed ID: 16932402
[TBL] [Abstract][Full Text] [Related]
27. The metabolic puzzle during the evolution of HIV infection.
Salas-Salvadó J; García-Lorda P
Clin Nutr; 2001 Oct; 20(5):379-91. PubMed ID: 11534932
[TBL] [Abstract][Full Text] [Related]
28. Bilateral lipomastia in men: a side effect of highly active antiretroviral therapy.
Deonarain J; Ramdial PK; Singh B
Int J Surg Pathol; 2008 Apr; 16(2):171-5. PubMed ID: 18417674
[TBL] [Abstract][Full Text] [Related]
29. HIV-associated distal sensory polyneuropathy in the era of highly active antiretroviral therapy: the Manhattan HIV Brain Bank.
Morgello S; Estanislao L; Simpson D; Geraci A; DiRocco A; Gerits P; Ryan E; Yakoushina T; Khan S; Mahboob R; Naseer M; Dorfman D; Sharp V;
Arch Neurol; 2004 Apr; 61(4):546-51. PubMed ID: 15096404
[TBL] [Abstract][Full Text] [Related]
30. HIV infection, body composition changes and related metabolic complications: contributing factors and evolving management strategies.
Falutz J
Curr Opin Clin Nutr Metab Care; 2011 May; 14(3):255-60. PubMed ID: 21460720
[TBL] [Abstract][Full Text] [Related]
31. Switching effective antiretroviral therapy: a review.
Drechsler H; Powderly WG
Clin Infect Dis; 2002 Nov; 35(10):1219-30. PubMed ID: 12410482
[TBL] [Abstract][Full Text] [Related]
32. [HIV disease, antiretroviral treatment and the liver--emerging problems].
Manfredi R
Recenti Prog Med; 2003 Apr; 94(4):149-53. PubMed ID: 12677783
[TBL] [Abstract][Full Text] [Related]
33. Metabolic complications of HIV-1 antiretroviral therapy: the lipodystrophy syndrome.
Borderi M; Verucchi G; Tadolini M; Spinosa S; Fortunato L; Talò S; Chiodo F
New Microbiol; 2001 Jul; 24(3):303-15. PubMed ID: 11497090
[TBL] [Abstract][Full Text] [Related]
34. Hyperlactataemia and lactic acidosis in HIV-infected patients receiving antiretroviral therapy.
Calza L; Manfredi R; Chiodo F
Clin Nutr; 2005 Feb; 24(1):5-15. PubMed ID: 15681097
[TBL] [Abstract][Full Text] [Related]
35. Fatal lactic acidosis associated with highly active antiretroviral therapy in patients with advanced human immunodeficiency virus infection in Taiwan.
Sheng WH; Hsieh SM; Lee SC; Chen MY; Wang JT; Hung CC; Chang SC
Int J STD AIDS; 2004 Apr; 15(4):249-53. PubMed ID: 15075019
[TBL] [Abstract][Full Text] [Related]
36. Managing issues related to antiretroviral therapy.
Lesho EP; Gey DC
Am Fam Physician; 2003 Aug; 68(4):675-86. PubMed ID: 12952384
[TBL] [Abstract][Full Text] [Related]
37. Fanconi syndrome and lactic acidosis associated with stavudine and lamivudine therapy.
Nelson M; Azwa A; Sokwala A; Harania RS; Stebbing J
AIDS; 2008 Jul; 22(11):1374-6. PubMed ID: 18580619
[TBL] [Abstract][Full Text] [Related]
38. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
[TBL] [Abstract][Full Text] [Related]
39. Antiretroviral therapy affects the composition of weight loss in HIV infection: implications for clinical nutrition.
Maia BS; Engelson ES; Wang J; Kotler DP
Clin Nutr; 2005 Dec; 24(6):971-8. PubMed ID: 16095765
[TBL] [Abstract][Full Text] [Related]
40. Fatal lactic acidosis and mimicking Guillain-Barré syndrome in an adolescent with human immunodeficiency virus infection.
Rosso R; Di Biagio A; Ferrazin A; Bassetti M; Ciravegna BW; Bassetti D
Pediatr Infect Dis J; 2003 Jul; 22(7):668-70. PubMed ID: 12886900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
